Last Price$222.71.6%
Market Cap$21.9B
LTM Net Income
$467.6M
YoY Growth
-17.5%
3Y CAGR
+18.8%
5Y CAGR
+3.5%
Stock quality & Intrinsic value
6/10
10.4% overvalued
STERIS plc Net Income
Annual
Quarterly
LTM
Crunching data... Almost there!
| Mar'05 | Mar'06 | Mar'07 | Mar'08 | Mar'09 | Mar'10 | Mar'11 | Mar'12 | Mar'13 | Mar'14 | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | $86.0M | $70.3M | $82.2M | $77.1M | $110.7M | $128.5M | $51.3M | $136.1M | $160.0M | $129.4M | $135.1M | $110.8M | $110.0M | $290.9M | $304.1M | $407.7M | $397.4M | $243.9M | $107.0M | $378.2M |
Overvalued or undervalued?
Check the intrinsic value for STE
and see if it's the right time to invest.
STERIS plc (STE) Net Income comparison analysis
General
LTM Net Income
Growth
Company name
YoY growth
3Y CAGR
5Y CAGR
STERIS plcSTE
$467.6M
(17.5%)
18.8%
3.5%
Median Peer Set
$1,257.2M
11.3%
20.8%
3.8%
Abbott LaboratoriesABT
$13.4B
134.2%
23.8%
29.4%
Medtronic plcMDT
$4,260.0M
1.4%
(4.7%)
(4.3%)
Edwards Lifesciences CorporationEW
$4,158.9M
190.6%
41.2%
40.0%
Stryker CorporationSYK
$2,993.0M
(5.4%)
14.5%
7.5%
Boston Scientific CorporationBSX
$1,850.0M
16.1%
23.3%
(17.0%)
Zimmer Biomet Holdings, Inc.ZBH
$664.4M
(35.1%)
18.3%
(10.1%)
DexCom, Inc.DXCM
$576.2M
6.4%
55.0%
41.6%
Align Technology, Inc.ALGN
$421.4M
(5.3%)
(18.3%)
(1.0%)
Insulet CorporationPODD
$418.3M
102.8%
188.6%
104.9%
Koninklijke Philips N.V.PHG
($758.3M)
51.1%
N/A
N/A
STE key stats
USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
| Mar'05 | Mar'06 | Mar'07 | Mar'08 | Mar'09 | Mar'10 | Mar'11 | Mar'12 | Mar'13 | Mar'14 | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
% growth | 1,119.7 3.0% | 1,160.3 3.6% | 1,197.4 3.2% | 1,265.1 5.7% | 1,298.5 2.6% | 1,257.7 (3.1%) | 1,207.4 (4.0%) | 1,391.5 15.2% | 1,501.9 7.9% | 1,622.3 8.0% | 1,850.3 14.1% | 2,238.8 21.0% | 2,612.8 16.7% | 2,620.0 0.3% | 2,782.2 6.2% | 3,030.9 8.9% | 3,107.5 2.5% | 4,585.1 47.5% | 4,957.8 8.1% | 5,138.7 3.6% |
| Cost of Goods Sold (COGS) | 648.1 | 676.1 | 692.6 | 741.1 | 771.8 | 718.6 | 761.3 | 823.0 | 880.6 | 972.6 | 1,076.0 | 1,343.3 | 1,587.1 | 1,525.8 | 1,606.7 | 1,711.0 | 1,764.4 | 2,568.7 | 2,798.1 | 2,920.5 |
% margin | 471.7 42.1% | 484.2 41.7% | 504.8 42.2% | 524.0 41.4% | 526.7 40.6% | 539.2 42.9% | 446.2 37.0% | 568.5 40.9% | 621.3 41.4% | 649.6 40.0% | 774.3 41.8% | 895.5 40.0% | 1,025.6 39.3% | 1,094.2 41.8% | 1,175.4 42.2% | 1,319.9 43.5% | 1,343.1 43.2% | 2,016.4 44.0% | 2,159.7 43.6% | 2,218.2 43.2% |
| Operating Expenses | 326.7 | 349.2 | 360.5 | 385.0 | 347.7 | 330.6 | 359.7 | 345.5 | 395.8 | 429.6 | 547.5 | 683.4 | 739.5 | 690.7 | 733.0 | 782.3 | 797.6 | 1,590.7 | 1,400.5 | 1,382.0 |
| Research & Development Expenses (R&D) | 35.5 | 33.6 | 33.6 | 36.9 | 32.8 | 34.0 | 34.3 | 36.0 | 41.3 | 48.6 | 54.1 | 56.7 | 59.4 | 60.8 | 63.0 | 65.5 | 66.3 | 87.9 | 101.6 | 103.7 |
| Selling, General & Administrative Expenses (SG&A) | 291.1 | 315.6 | 326.9 | 348.0 | 315.0 | 296.6 | 325.5 | 309.6 | 354.5 | 381.0 | 493.3 | 626.7 | 680.1 | 629.9 | 669.9 | 716.7 | 731.3 | 1,502.8 | 1,298.9 | 1,252.3 |
% margin | 145.0 12.9% | 109.7 9.5% | 137.7 11.5% | 123.5 9.8% | 175.4 13.5% | 203.7 16.2% | 85.2 7.1% | 222.3 16.0% | 242.8 16.2% | 206.8 12.7% | 227.2 12.3% | 212.9 9.5% | 227.6 8.7% | 403.5 15.4% | 411.5 14.8% | 341.1 11.3% | 323.3 10.4% | 425.6 9.3% | 268.2 5.4% | 836.1 16.3% |
| Interest Income | 0.0 | 0.0 | 0.0 | 0.0 | 1.6 | 1.3 | 0.6 | 0.9 | 0.0 | 0.3 | 0.8 | 1.7 | 1.6 | 2.2 | 3.0 | 2.0 | 6.3 | 6.3 | 108.0 | 11.0 |
| Interest Expense | 3.1 | 44.9 | 16.9 | 34.7 | 10.6 | 13.2 | 12.0 | 12.1 | 15.7 | 18.8 | 19.2 | 42.7 | 44.5 | 50.6 | 45.0 | 40.3 | 37.2 | 89.6 | 109.6 | 144.4 |
| Pre-tax Income | 141.9 | 108.1 | 132.9 | 119.8 | 166.5 | 191.8 | 73.8 | 211.1 | 227.1 | 188.4 | 208.8 | 171.9 | 184.6 | 355.0 | 369.5 | 498.7 | 517.5 | 314.5 | 157.3 | 702.8 |
% effective tax rate | 56.0 39.4% | 45.2 41.8% | 51.8 39.0% | 42.7 35.6% | 55.8 33.5% | 63.3 33.0% | 22.6 30.6% | 75.0 35.5% | 67.1 29.6% | 58.9 31.3% | 73.8 35.3% | 60.3 35.1% | 74.0 40.1% | 63.4 17.8% | 64.4 17.4% | 90.9 18.2% | 120.7 23.3% | 71.6 22.8% | 51.5 32.8% | 149.5 21.3% |
% margin | 86.0 7.7% | 70.3 6.1% | 82.2 6.9% | 77.1 6.1% | 110.7 8.5% | 128.5 10.2% | 51.3 4.2% | 136.1 9.8% | 160.0 10.7% | 129.4 8.0% | 135.1 7.3% | 110.8 4.9% | 110.0 4.2% | 290.9 11.1% | 304.1 10.9% | 407.7 13.5% | 397.4 12.8% | 243.9 5.3% | 107.0 2.2% | 378.2 7.4% |
| EPS | 1.24 | 1.03 | 1.26 | 1.22 | 1.88 | 2.18 | 0.86 | 2.33 | 2.74 | 2.20 | 2.27 | 1.57 | 1.29 | 3.42 | 3.59 | 4.81 | 4.66 | 2.50 | 1.07 | 3.83 |
| Diluted EPS | 1.23 | 1.02 | 1.25 | 1.20 | 1.86 | 2.16 | 0.85 | 2.31 | 2.72 | 2.17 | 2.25 | 1.56 | 1.28 | 3.39 | 3.56 | 4.76 | 4.63 | 2.48 | 1.07 | 3.81 |
% margin | 196.2 17.5% | 171.0 14.7% | 200.4 16.7% | 188.6 14.9% | 235.8 18.2% | 261.2 20.8% | 140.4 11.6% | 286.1 20.6% | 294.5 19.6% | 303.8 18.7% | 319.5 17.3% | 438.7 19.6% | 503.0 19.3% | 594.5 22.7% | 693.1 24.9% | 743.2 24.5% | 800.3 25.8% | 957.2 20.9% | 1,344.0 27.1% | 1,412.4 27.5% |
Discover more Stock Ideas
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
3M Return 32.1%
S&P Outperformance 19.1%
Next 3M Predicted Return 20.3%
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
3M Return 35.3%
S&P Outperformance 22.3%
Next 3M Predicted Return 26.8%
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.
3M Return 28.4%
S&P Outperformance 15.4%
Next 3M Predicted Return 16.9%
FAQ
1) What is STERIS plc's Net Income?
As of today, STERIS plc's last 12-month Net Income is $467.6M, based on the financial report for Dec 31, 2024 (Q4’2024).
2) What is STERIS plc's Net Income growth rate?
Over the last year, STERIS plc's Net Income growth was (17.5%). The average annual Net Income growth rates for STERIS plc have been 17.8% over the past three years, 3.5% over the past five years.
3) Is STERIS plc's Net Income growth rate Good?
Over the last year, STERIS plc's Net Income growth was (17.5%), which is lower than industry growth of (0.2%). It indicates that STERIS plc's Net Income growth is Bad.